相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis
Ying Qing et al.
MOLECULAR CELL (2021)
EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma
Runping Fang et al.
NATURE COMMUNICATIONS (2021)
Clinical practice guidelines for the management of adult diffuse gliomas
Tao Jiang et al.
CANCER LETTERS (2021)
Chinese Glioma Genome Atlas (CGGA) : A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients
Zheng Zhao et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2021)
METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma
Yu-Zhou Chang et al.
CANCER LETTERS (2021)
Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
Ruichao Chai et al.
CANCER BIOLOGY & MEDICINE (2021)
ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism
Valentina Tassinari et al.
GENOME BIOLOGY (2021)
LncRNA PRADX-mediated recruitment of PRC2/DDX5 complex suppresses UBXN1 expression and activates NF-KB activity, promoting tumorigenesis
Yansheng Li et al.
THERANOSTICS (2021)
Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer
Qiang Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation
Rui-Chao Chai et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
RNA modifications in brain tumorigenesis
Albert Z. Huang et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Role of CX3CR1 signaling in malignant transformation of gliomas
Sungho Lee et al.
NEURO-ONCOLOGY (2020)
YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation
Chuanzhao Zhang et al.
ONCOGENE (2020)
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
Barbara Oldrini et al.
NATURE COMMUNICATIONS (2020)
Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas
Yu-Zhou Chang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer
Zhixian Liang et al.
CANCER BIOLOGY & MEDICINE (2020)
PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma
Zuoxin Zhang et al.
CANCER LETTERS (2019)
YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma
Li Zhong et al.
CANCER LETTERS (2019)
Endoribonucleolytic Cleavage of m6A-Containing RNAs by RNase P/MRP Complex
Ok Hyun Park et al.
MOLECULAR CELL (2019)
Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma
Rui-Chao Chai et al.
CARCINOGENESIS (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
N6-Methyladenosine Modulates Nonsense-Mediated mRNA Decay in Human Glioblastoma
Fuxi Li et al.
CANCER RESEARCH (2019)
The interplay between m6A RNA methylation and noncoding RNA in cancer
Shuai Ma et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
m6A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas
Rui-Chao Chai et al.
AGING-US (2019)
RNA processing genes characterize RNA splicing and further stratify lower-grade glioma
Rui-Chao Chai et al.
JCI INSIGHT (2019)
Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance
A. Visvanathan et al.
ONCOGENE (2018)
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
Rui Su et al.
CELL (2018)
Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism
Ying Yang et al.
CELL RESEARCH (2018)
Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome
Romain Appay et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
NF-κB, Mesenchymal Differentiation and Glioblastoma
Bakhtiar Yamini
CELLS (2018)
Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor
Huimin Hu et al.
CELL (2018)
m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells
Qi Cui et al.
CELL REPORTS (2017)
Dynamic RNA Modifications in Gene Expression Regulation
Ian A. Roundtree et al.
CELL (2017)
miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma
Fan Yang et al.
CANCER LETTERS (2017)
The CRISPR/Cas9 system targeting EGFR exon 17 abrogates NF-κB activation via epigenetic modulation of UBXN1 in EGFRwt/vIII glioma cells
Kai Huang et al.
CANCER LETTERS (2017)
An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers
Genaro R. Villa et al.
CANCER CELL (2016)
Clonal evolution of glioblastoma under therapy
Jiguang Wang et al.
NATURE GENETICS (2016)
YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex
Hao Du et al.
NATURE COMMUNICATIONS (2016)
Uncoupling Nuclear Receptor LXR and Cholesterol Metabolism in Cancer
Fabiola Bovenga et al.
CELL METABOLISM (2015)
Ubiquitin-associated Domain-containing Ubiquitin Regulatory X (UBX) Protein UBXN1 Is a Negative Regulator of Nuclear Factor κB (NF-κB) Signaling
Yu-Bo Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
N6-methyladenosine-dependent regulation of messenger RNA stability
Xiao Wang et al.
NATURE (2014)
AQP5 is differentially regulated in astrocytes during metabolic and traumatic injuries
Rui Chao Chai et al.
GLIA (2013)
Genome-wide Repression of NF-κB Target Genes by Transcription Factor MIBP1 and Its Modulation by O-Linked β-N-Acetylglucosamine (O-GlcNAc) Transferase
Yuji Iwashita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
分享论文
